Prednisolone or Pentoxifylline for Alcoholic Hepatitis | Zendy

Mark J. DiNubile | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

Author(s) -

Mark J. DiNubile

Publication year - 2015

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmc1506342

Subject(s) - medicine , pentoxifylline , prednisolone , alcoholic hepatitis , alcoholic liver disease , hepatitis , gastroenterology , pharmacology , cirrhosis

Copyright © 2015 Massachusetts Medical Society. BACKGROUND Alcoholic hepatitis is a clinical syndrome characterized by jaundice and liver impairment that occurs in patients with a history of heavy and prolonged alcohol use. The short-term mortality among patients with severe disease exceeds 30%. Prednisolone and pentoxifylline are both recommended for the treatment of severe alcoholic hepatitis, but uncertainty about their benefit persists.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research